Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1

Clinical trial NCT05832073 · UNKNOWN

Trial details

NCT number: NCT05832073
Sponsor: Changchun BCHT Biotechnology Co.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Rabies Virus Infection

Start date: 2023-04-30
Primary completion: 2023-12-30
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.